Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Neuroblastoma 2Neoplasms 2Meningioma 2Medulloblastoma 2Thyroid Cancer, Papillary 1Pain 1Neuroendocrine Tumors 1Nausea 1Hematologic Neoplasms 1Fatigue 1Depression 1Anxiety Disorders 1

Interventions

pembrolizumab 185Gemcitabine 170Paclitaxel 152Carboplatin 137Bevacizumab 128Surveys and Questionnaires 118Cisplatin 115Docetaxel 114Blood Specimen Collection 110Cyclophosphamide 109Exercise 108Nivolumab 98Fluorouracil 90Capecitabine 86Dexamethasone 81Radiotherapy 80Irinotecan 74Standard of Care 69Pemetrexed 68Oxaliplatin 68Leucovorin 64Drug Therapy 64Cetuximab 60Erlotinib Hydrochloride 56Sorafenib 53atezolizumab 52Ipilimumab 51Doxorubicin 50trametinib 47Interviews as Topic 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms × Whole Body Imaging × Clear all
NCT05024929 2025-11-14

Targeted Therapy to Increase RAI Uptake in Metastatic DTC

Children's Hospital of Philadelphia

Recruiting
32 enrolled
EndocrineHead & Neck

Thyroid Cancer, Papillary, Neoplasms

NCT05433636 2024-02-06

Mindful Waiting Room

University of Utah

Phase NA Unknown
305 enrolled

Anxiety Disorders, Depression, Fatigue, Nausea, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡